Nordic Bioscience (Denmark)

Recent papers from Nordic Bioscience (Denmark)

1. The antifibrotic effect of empagliflozin: Insights from the EMPIRE trial programmeEuropean Heart Journal · 2026
2. Plasma level of extracellular matrix biomarkers is associated with the recurrence of atrial fibrillationEuropean Heart Journal · 2026
3. PRO-C6 and endotrophin are associated with cardiac remodelling and adverse outcomes in HFpEF: data from the prospective NETDiamond cohortEuropean Heart Journal · 2026
4. Elevated formation of collagen type III and VI after ablation reflects recurrence of atrial fibrillationEuropean Heart Journal · 2026
5. Prevalence and mortality of chronic extracellular matrix dysregulated diseases: a nationwide register-based studyThe Lancet Regional Health - Europe · 2026
6. Obesity – a key driver in osteoarthritisJournal of the Endocrine Society · 2026
7. Circulating Extracellular Matrix Biomarkers in the Detection of Carcinoid Heart DiseaseEndocrine Oncology · 2026
8. Circulating and matrix-associated type XI collagen epitopes as complementary biomarkers to support stromal-targeting concepts in solid tumorsBiomedicine & Pharmacotherapy · 2026
9. Systemic concentrations of cartilage oligomeric matrix protein, neo-epitope of MMP-derived type III collagen fragment, and propeptide of type IV collagen are greater in those at risk of post-traumatic osteoarthritis in comparison to matched controlsArthritis Research & Therapy · 2026
10. Multimodal profiling establishes ovarian fibrosis as a measurable and targetable hallmark of human reproductive aging2026
11. Collagen remodeling is elevated in fibrotic hypersensitivity pneumonitis and may distinguish it from idiopathic pulmonary fibrosisBMC Pulmonary Medicine · 2026
12. Calprotectin identified as a key differentially expressed plasma biomarker in periprosthetic joint infection against aseptic failure: a precision health proteomics studyArthroplasty · 2026
13. Investigation of non-invasive tests for fibrosis diagnosis and prognostication of events in metabolic dysfunction-associated steatotic liver disease: A prospective study cohortAnnals of Hepatology · 2026
14. Fibrogenesis Biomarkers and Clinical Disease Progression in ADPKDKidney International Reports · 2026
15. Circulating biomarkers reflecting type III, IV and VI collagen remodeling are present in lung tissue of patients with pulmonary fibrosis and non-fibrotic controlsScientific Reports · 2026
16. Combination therapy of RAS inhibition and glucagon-like peptide-1 receptor agonist improves a marker of kidney fibrosis in people with type 2 diabetesAJP Cell Physiology · 2026
17. Endotrophin Measured by PRO ‐ C6 as a Prognostic Biomarker for Liver‐Related Events in Patients With Advanced Chronic Liver DiseaseLiver International · 2026
18. Proteomic analysis of plasma and extracellular vesicles from subjects with impaired vascular healthBioscience Reports · 2026
19. Collagen Turnover Is Associated with Disease Severity, Bone Marrow Fibrosis, and the JAK2V617F Variant Allele Frequency in Myeloproliferative NeoplasmsCancers · 2026
20. Resolution of systemic inflammation in psoriasis following herring roe oil treatment: a post hoc analysis on inflammatory biomarkers in non-severe psoriatic patientsFrontiers in Medicine · 2026